Genmab — April 2018
-
GEN is always the target of overreactions.. nothing suprises me anymore in this matter
-
New: Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors
https://clinicaltrials.gov/ct2/show/NCT03485209?term=daratumumab+OR+ofatumumab+OR+tisotumab&lupd_s=03%2F29%2F2018&rank=3 -
@mayflower : nej, netop !
-
Ofatumumab Safe, Effective for B Cell Depletion in Rituximab-Intolerant SLE,
Rheumatology Advisor, http://www.rheumatologyadvisor.com/systemic-lupus-erythematosus/ofatumumab-effective-for-b-cell-depletion-in-systemic-lupus-erythematosus/article/755223/ -
Hvor ender vi i dag?
-
Købte nogle bulls i morges som jeg skal have fyret af.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind